Prosecution Insights
Browse Companies Examiners Firms Draft Your Response
Home / Genentech Inc. / Complete list
Last updated: October 22, 2026

Genentech Inc.: all pending office actions

← Back to Genentech Inc.

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19409123 CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION TAYLOR, LIA ELAN 1641 §103 Final Rejection — Pending Dec 04, 2025
19288834 GENERATIVE PROTEIN DESIGN WITH SMOOTHED ENERGY-BASED MODELS BICKHAM, DAWN MARIE 1685 §101 Final Rejection — Pending Aug 01, 2025
19076588 CROSS-MODALITY PIXEL ALIGNMENT AND CELL-TO-CELL REGISTRATION ACROSS VARIOUS IMAGING MODALITIES JONES, ANDREW B — §103§112 Non-Final OA — Pending Mar 11, 2025
19029418 DEEP LEARNING FOR NEW AND ENLARGING LESIONS USTARIS, JOSEPH G 2483 §103 Non-Final OA — Pending Jan 17, 2025
18981116 DETECTING LONGITUDINAL PROGRESSION OF ALZHEIMER'S DISEASE (AD) BASED ON SPEECH ANALYSES SAINT CYR, LEONARD 2658 §103 Non-Final OA — Pending Dec 13, 2024
18981081 MICROSCOPE SLIDE IMAGE-BASED MACHINE LEARNING IMAGE ANALYSIS FOR INFLAMMATORY BOWEL DISEASE SALEH, ZAID MUHAMMAD 2668 §102§103 Non-Final OA — Pending Dec 13, 2024
18939497 MACHINE LEARNING ENABLED DIAGNOSIS AND LESION LOCALIZATION FOR NASCENT GEOGRAPHIC ATROPHY IN AGE-RELATED MACULAR DEGENERATION YANG, WEI WEN 2662 §102§103 Non-Final OA — Pending Nov 06, 2024
18933358 BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS HALVORSON, MARK 1646 §103Other Non-Final OA — Pending Oct 31, 2024
18929474 MACHINE LEARNING ENABLED HEPATOCELLULAR CARCINOMA MOLECULAR SUBTYPE CLASSIFICATION DHOOGE, DEVIN J 2677 §103 Non-Final OA — Pending Oct 28, 2024
18859952 DRUG PRODUCTION METHOD GAVIN, KRISTIN ELIZABETH 3624 §101§103 Non-Final OA 40d Pending Oct 24, 2024
18859397 SOLID FORM OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3- FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9- TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL TARTRATE WELLS, LAUREN QUINLAN 1622 §103§112DP Non-Final OA — Pending Oct 23, 2024
18911076 ANOMALY DETECTION IN MEDICAL IMAGING DATA NGUYEN, TUAN HOANG 2649 DP Non-Final OA — Pending Oct 09, 2024
18909867 PATHOLOGICAL RESPONSE CALCULATION AND ASSESSMENT TOOL NGUYEN, TUAN HOANG 2649 §103Other Non-Final OA — Pending Oct 08, 2024
18846553 DETERMINING A PATIENT’S RESPONSE TO A TREATMENT IN MULTIPLE MYELOMA LEE, ANDREW ELDRIDGE 3684 §101§103 Final Rejection — Pending Sep 12, 2024
18820925 PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA MOEHLMAN, ANDREW TERRY 1655 §112 Non-Final OA — Pending Aug 30, 2024
18817828 TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING AN ATP COMPETITIVE AKT INHIBITOR, A CDK4/6 INHIBITOR, AND FULVESTRANT KOSTURKO, GEORGE W 1621 §102§103DP Non-Final OA — Pending Aug 28, 2024
18799503 THERAPEUTIC AND DIAGNOSTIC METHODS FOR BLADDER CANCER GUSTILO, ESTELLA M 1646 §102§103§112Other Non-Final OA — Pending Aug 09, 2024
18793023 DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE HOWELL, THEODORE R 1628 §103DP Non-Final OA — Pending Aug 02, 2024
18785844 CDK INHIBITORS RODRIGUEZ, RAYNA B 1628 §112Other Non-Final OA — Pending Jul 26, 2024
18771363 OVARIAN TOXICITY ASSESSMENT IN HISTOPATHOLOGICAL IMAGES USING DEEP LEARNING NGUYEN, KHAI MINH 2641 §103Other Non-Final OA — Pending Jul 12, 2024
18752501 MULTI-VECTOR RECOMBINASE MEDIATED CASSETTE EXCHANGE KONOPKA, CATHERINE ANNE 1635 §103§112DP Non-Final OA 78d overdue Pending Jun 24, 2024
18734329 SOLID FORMULATIONS COMPRISING AN INHIBITOR OF THE K-RAS PROTEIN HAVING A G12C MUTATION, AND A PROCESS FOR PREPARING PALLAY, MICHAEL B 1617 §103§112 Non-Final OA — Pending Jun 05, 2024
18669218 SYNTHETIC CONTROLS FOR IMMUNOHISTOCHEMISTRY NGUYEN, NAM P 1678 §103 Non-Final OA 22d overdue Pending May 20, 2024
18668774 METHODS OF TREATING CANCER WITH PI3K INHIBITOR, GDC-0077 BAEK, BONG-SOOK 1611 §103Other Non-Final OA — Pending May 20, 2024
18710130 BRM DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE MCKOY, QUINCY ANDRE 1626 §102§112 Non-Final OA — Pending May 14, 2024
18651221 CELL CULTURE COMPOSITIONS WITH ANTIOXIDANTS AND METHODS FOR POLYPEPTIDE PRODUCTION BELYAVSKYI, MICHAIL A 1644 §102 Non-Final OA — Pending Apr 30, 2024
18642305 HIGH-THROUGHPUT METHODS FOR PREPARING LIPID NANOPARTICLES AND USES THEREOF MITCHELL, EDWIN COLEMAN 1619 §102§103§112DP Non-Final OA — Pending Apr 22, 2024
18636947 CELL-BASED ASSAY FOR DETECTING ANTl-CD3 HOMODIMERS BELYAVSKYI, MICHAIL A 1644 §102Other Non-Final OA — Pending Apr 16, 2024
18698664 CYCLOPENTYLPYRAZOLE CDK2 INHIBITORS MARTIN, KEVIN STEPHEN 1624 §102§103 Final Rejection — Pending Apr 04, 2024
18612141 USES OF IL-13 ANTAGONISTS FOR TREATING ATOPIC DERMATITIS CHATTIN, AMY MARIE 1643 §103DP Non-Final OA — Pending Mar 21, 2024
18612987 PIPELINES FOR TUMOR IMMUNOPHENOTYPING VARNDELL, ROSS E 2674 §101§103 Final Rejection — Pending Mar 21, 2024
18611567 DATA QUALITY CONTROL AND INTEGRATION FOR DIGITAL PATHOLOGY RAJAPUTRA, SUMAN 2172 §101§103 Non-Final OA — Pending Mar 20, 2024
18604429 METABOLOMIC ANALYSIS FRITCHMAN, REBECCA M 1758 §112 Non-Final OA — Pending Mar 13, 2024
18600194 PHARMACEUTICAL COMPOSITIONS OF MOSUNETUZUMAB AND METHODS OF USE KIM, YUNSOO 1641 §103DP Non-Final OA — Pending Mar 08, 2024
18593665 ION EXCHANGE MEMBRANE CHROMATOGRAPHY PUTTLITZ, KARL J 1644 §112DP Non-Final OA — Pending Mar 01, 2024
18590267 METHOD FOR TREATING MULTIPLE SCLEROSIS WEN, SHARON X 1641 §102§112DP Non-Final OA — Pending Feb 28, 2024
18587251 METHODS OF TREATING TAU PATHOLOGIES JUEDES, AMY E 1644 §102DP Non-Final OA — Pending Feb 26, 2024
18584311 SODIUM CHANNEL INHIBITORS AND METHODS OF DESIGNING SAME YOO, SUN JAE 1621 §102 Non-Final OA — Pending Feb 22, 2024
18431838 METHOD AND APPARATUS FOR BIOLOGICAL CELL HARVESTING COOLEY, CHARLES E 1774 §103 Non-Final OA — Pending Feb 02, 2024
18429055 METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS MACFARLANE, STACEY NEE 1675 §102§112DP Non-Final OA — Pending Jan 31, 2024
18416031 Anti-Jagged1 Antibodies and Methods of Use GUSTILO, ESTELLA M 1646 §112DP Non-Final OA — Pending Jan 18, 2024
18412348 AUTOMATED DIGITAL ASSESSMENT OF HISTOLOGIC SAMPLES CRUZ, IRIANA 2681 §103 Non-Final OA — Pending Jan 12, 2024
18410827 MINICOLUMN RETAINING APPARATUS AND METHOD OF USE JARRETT, LORE RAMILLANO 1797 §102§103 Non-Final OA — Pending Jan 11, 2024
18544236 METHODS OF TREATING CANCER USING B-RAF INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS RODRIGUEZ, RAYNA B 1628 §103 Final Rejection — Pending Dec 18, 2023
18540310 EGFR INHIBITOR AND PERK ACTIVATOR IN COMBINATION THERAPY AND THEIR USE FOR TREATING CANCER DEKARSKE, MADELINE MCGUIRE 1622 §103§112 Non-Final OA — Pending Dec 14, 2023
18523284 HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS SHIAO, REI TSANG 1691 §103§112 Non-Final OA 91d overdue AI Ready Nov 29, 2023
18516552 DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER SCHMITT, MICHAEL J 1629 §103Other Non-Final OA 55d Pending Nov 21, 2023
18510297 COMBINED TRANSPOSON-MEDIATED INTEGRATION AND TARGETED INTEGRATION OF NUCLEIC ACIDS INTO HOST CELLS MEYERING, SHABANA SHABBEER 1635 §103§112DP Non-Final OA — Pending Nov 15, 2023
18504041 ANTI-LY6G6D ANTIBODIES AND METHODS OF USE MOSELEY II, NELSON B 1642 Other Non-Final OA — Pending Nov 07, 2023
18493957 Chimeric ABC Transporters and Screening Methods STEPHENS, AMELIA CAROLE 1600 §101§103§112 Non-Final OA — Pending Oct 25, 2023
18486325 IN VITRO CELL-BASED ASSAY FOR PREDICTING PHARMACOKINETICS AND BRAIN PENETRATION OF BIOLOGICS HOFFMAN, ALEXANDER JOSEPH 1677 §103§112 Non-Final OA — Pending Oct 13, 2023
18482237 TREATMENT OUTCOME PREDICTION FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION USING BASELINE CHARACTERISTICS WINDSOR, COURTNEY J 2661 §103 Non-Final OA 31d overdue Pending Oct 06, 2023
18464580 ANTI-KLK7 ANTIBODIES, ANTI-KLK5 ANTIBODIES, MULTISPECIFIC ANTI-KLK5/KLK7 ANTIBODIES, AND METHODS OF USE SHUPE, ELIZABETH A 1643 §112 Non-Final OA 4d overdue Pending Sep 11, 2023
18463585 ATTENTION-BASED MULTIPLE INSTANCE LEARNING FOR WHOLE SLIDE IMAGES TRAN, DUY ANH 2674 §102 Non-Final OA 13d Pending Sep 08, 2023
18464135 PREDICTION OF DISTRIBUTION OF GLYCANS ATTACHED TO MOLECULES MANUFACTURED IN A CELL CULTURE STUBBS, JOHN THOMAS 1686 §101§102§103§112 Non-Final OA — Pending Sep 08, 2023
18463118 ESTIMATING HLA EXPRESSION LOSS AUGER, NOAH ANDREW 1687 §101§103§112 Non-Final OA — Pending Sep 07, 2023
18449793 TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING GDC-9545 AND ABEMACICLIB OR RIBOCICLIB CHAO, ALLEN 1622 §103 Non-Final OA — Pending Aug 15, 2023
18447986 ESTIMATION OF MECHANISTIC CHROMATOGRAPHY MODEL UNCERTAINTY GEBRESILASSIE, KIBROM K 2189 §101§102 Non-Final OA — Pending Aug 10, 2023
18363155 Multispecific Binding Protein Degrader Platform and Methods of Use MELCHIOR, JAMES RYLAND 1644 §102§103§112Other Non-Final OA — Pending Aug 01, 2023
18210604 ASSEMBLY OF BISPECIFIC ANTIBODIES HUYNH, PHUONG N 1641 Other Final Rejection 111d overdue Pending Jun 15, 2023
18206853 METHODS FOR DETERMINING THE RELATIVE DISTRIBUTION OF GLUCURONIDATION, IDURONIDATION, AND GALACTURONIDATION OF POLYPEPTIDES SIMMONS, VALERIE MICHELLE 1758 §103 Final Rejection 34d Pending Jun 07, 2023
18329972 THERAPEUTIC AND DIAGNOSTIC METHODS FOR IL-33-MEDIATED DISORDERS SITTON, JEHANNE SOUAYA 1682 §103 Final Rejection 52d overdue Pending Jun 06, 2023
18204281 INDUCTIVE HEAT STERILIZING SYSTEMS, DEVICES, AND METHODS LEE, AHAM NMN 1758 §103 Final Rejection 14d Pending May 31, 2023
18324406 METHODS FOR MODULATING HOST CELL SURFACE INTERACTIONS WITH HUMAN CYTOMEGALOVIRUS CUNNINGCHEN, KATHLEEN MARY 1646 §112 Non-Final OA — Pending May 26, 2023
18201904 METHODS FOR PREPARING MAMMALIAN CELLS FOR PERFUSION CELL CULTURE MONTANARI, DAVID A 1632 §102§103 Non-Final OA — Pending May 25, 2023
18323240 PYRROLIDINE DERIVATIVES AND METHODS OF USE BELL, SARA ELIZABETH 1625 §112 Final Rejection 34d Pending May 24, 2023
18319618 Reusable Cartridges for Detecting Analytes in Solution MONTGOMERY, ANN Y 1678 §112 Non-Final OA — Pending May 18, 2023
18315450 SMALL PARTS CLEANING APPARATUS AND METHODS OF USE LEE, KEVIN G 1711 §103§112 Final Rejection 58d overdue Pending May 10, 2023
18195134 1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXY-N-(BENZYL)PYRROLIDIN E-2-CARBOXAMIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA AND CANCER WILSON, JERICA KATLYNN 1621 §103 Non-Final OA — Pending May 09, 2023
18309003 RECOMBINANT PROTEINS FOR QUANTIFICATION OF PROTEIN LEVELS NOAKES, SUZANNE MARIE 1656 §112 Non-Final OA — Pending Apr 28, 2023
18295539 DOSING FOR TREATMENT WITH ANTI-FCRH5/ANTI-CD3 BISPECIFIC ANTIBODIES ALLEN, MARIANNE P 1647 §112 Final Rejection 26d overdue Pending Apr 04, 2023
18194542 HYDROXYPROPYL METHYL CELLULOSE DERIVATIVES TO STABILIZE POLYPEPTIDES HARTLEY, MICHAEL G 1614 §103 Non-Final OA — Pending Mar 31, 2023
18190697 THERMAL SEPARATOR APPARATUS FOR FLASK STIRRER AND METHOD OF USE JARRETT, LORE RAMILLANO 1797 §103§112 Final Rejection — Pending Mar 27, 2023
18173673 POINT OF CARE DRUG DELIVERY APPARATUS AND METHOD STIGELL, THEODORE J 3783 §102§103 Final Rejection — Pending Feb 23, 2023
18173002 ASSAYS AND REAGENTS FOR CHARACTERIZATION OF MHCI PEPTIDE BINDING LUSI, ELLIS FOLLETT 1677 §103§112 Final Rejection 21d Pending Feb 22, 2023
18104825 T CELL-BASED METHODS FOR PREDICTING POLYPEPTIDE IMMUNOGENICITY GAO, ASHLEY HARTMAN 1600 §103 Non-Final OA — Pending Feb 02, 2023
18156744 ANTIBODY-CONJUGATED CHEMICAL INDUCERS OF DEGRADATION OF BRM AND METHODS THEREOF VAN DRUFF, SYDNEY 1643 §103DP Final Rejection 53d overdue Pending Jan 19, 2023
18089335 SUPRACHOROIDAL INJECTION DEVICE PRICE, NATHAN R 3783 §102§103 Non-Final OA — Pending Dec 27, 2022
18048986 METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES GODDARD, LAURA B 1642 §103 Final Rejection 10d overdue Pending Oct 24, 2022
18046865 METHODS FOR ASSAYING T-CELL DEPENDENT BISPECIFIC ANTIBODIES SKELDING, ZACHARY S 1644 §103DP Final Rejection 12d Pending Oct 14, 2022
17965363 Method for Enriching Extracellular Vesicles From Biological Fluid Samples BOESEN, CHRISTIAN C 1684 §102 Non-Final OA — Pending Oct 13, 2022
17964325 METHOD FOR MEDIUM TREATMENT BEFORE INOCULATION MOSS, NATALIE M 1653 §103§112 Non-Final OA 127d overdue Pending Oct 12, 2022
17947820 USE OF GENETIC ALGORITHMS TO DETERMINE A MODEL TO IDENTITY SAMPLE PROPERTIES BASED ON RAMAN SPECTRA THOMPSON, MILANA KAYE 1687 §103 Final Rejection — Pending Sep 19, 2022
17932885 SYSTEMS AND METHODS TO TRACK THE EVOLUTION OF SINGLE CELLS BOESEN, CHRISTIAN C 1684 §101§102§112 Non-Final OA — Pending Sep 16, 2022
17822746 EFFICIENT GENOME EDITING IN PRIMARY MYELOID CELLS VANHORN, ABIGAIL LOUISE 1636 §103 Final Rejection 87d overdue Pending Aug 26, 2022
17629327 DETECTING NEURALLY PROGRAMMED TUMORS USING EXPRESSION DATA MINCHELLA, KAITLYN L 1685 §103§112 Final Rejection 88d overdue Pending Jan 21, 2022
17643623 QUINAZOLINYL COMPOUNDS AND METHODS OF USE HIRAKIS, SOPHIA P 1623 §112 Non-Final OA — Pending Dec 10, 2021
17542138 METHOD FOR REGENERATION OF AN OVERLOAD CHROMATOGRAPHY COLUMN KIM, YUNSOO 1641 §103 Final Rejection — Pending Dec 03, 2021
17503122 ANTIBODY POTENCY ASSAY EVANS, CHRISTOPHER RYAN 1677 §103 Final Rejection 1d overdue Pending Oct 15, 2021
17490877 COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS NGUYEN, NGOC-ANH THI 1615 §103 Final Rejection 53d Pending Sep 30, 2021
17383316 METHOD FOR THE EXPRESSION OF AN ANTIBODY-MULTIMER-FUSION MIDDLETON, DANAYA L 1674 §112Other Non-Final OA — Pending Jul 22, 2021
17381145 IMMUNOGLOBULIN A ANTIBODIES AND METHODS OF PRODUCTION AND USE BRISTOL, LYNN ANNE 1643 §112 Non-Final OA — Pending Jul 20, 2021
17378651 ATTENTION-BASED NEURAL NETWORK TO PREDICT PEPTIDE BINDING, PRESENTATION, AND IMMUNOGENICITY BAILEY, STEVEN WILLIAM 1687 §101 Final Rejection 396d overdue Pending Jul 16, 2021
17229746 COPPER LOSS MITIGATION MIANO, JOSEPH PAUL 1631 §102§103§112 Final Rejection 9d Pending Apr 13, 2021
17172528 CELL CULTURE STRATEGIES FOR MODULATING PROTEIN GLYCOSYLATION AFREMOVA, VERA 1653 §102§103§112 Non-Final OA 49d overdue Pending Feb 10, 2021
17168621 USE OF TRYPTOPHAN DERIVATIVES AND L-METHIONINE FOR PROTEIN FORMULATION GAO, ASHLEY HARTMAN 1678 §103Other Final Rejection — Pending Feb 05, 2021
17075238 OVERLOAD AND ELUTE CHROMATOGRAPHY STONEBRAKER, ALYSSA RAE 1642 §103§112 Final Rejection 72d overdue Pending Oct 20, 2020
16115373 METHODS AND SYSTEMS FOR EVALUATING TUMOR MUTATIONAL BURDEN WOITACH, JOSEPH T 1687 §101§112 Final Rejection — Pending Aug 28, 2018

Data sourced from USPTO Patent File Wrapper (daily) and Office Action Archive (weekly). Analysis generated by IP Author.

Data: USPTO Patent File Wrapper (daily) • Office Action Archive (weekly) • 89M+ prosecution events

© 2026 IP Author — Browse Office Actions • Examiners • Companies • Firms

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month